Solid Tumors

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Dr Antonella Bresin Bresin

Istituto Dermopatico dell’Immacolata, Rome, Italy

Dr Gottfried E. Konecny

Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA

Prof. Adam E. Snook

Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA

Prof. Anwaar Saeed

University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA

Prof. Ibrahim Tarik Ozbolat

Penn State University, Pennsylvania, United States

Prof. Tony Y. Hu

School of Medicine, Tulane University, New Orleans, LA, USA

Prof. Zuo-Feng Zhang

Fielding School of Public Health, University of California, Los Angeles

Prof. Liying Zhang

David Geffen School of Medicine at UCLA,UCLA Jonsson Comprehensive Cancer Center, LA, USA

Prof. Dr Antonio Facchiano

Secretary General, EUSTM

Talks

Immunotherapy targets in melanoma and other cancer types

06 May 2023, 08:00 AM

GUCY2C-directed vaccines for GI cancer recurrence prevention

06 May 2023, 09:00 AM

Biomarkers for Immunotherapy

06 May 2023, 01:00 PM

A 3D Bioprinted Breast Cancer Model for Immunotherapy

06 May 2023, 03:00 PM

Antibody drug conjugates in Ovarian Cancer

07 May 2023, 09:00 AM

Scientific Session C: Solid Tumors Immunotherapeutics

07 May 2023, 10:00 AM

Life in a Bubble: Identifying novel biomarkers on extracellular vesicles for rapid disease diagnosis

07 May 2023, 12:00 PM

Updates on Immune biomarkers in Gastrointestinal Malignancies: Beyond Microsatellite Instability

07 May 2023, 04:00 PM

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Book My Place